Cocrystal pharma to present at the life science innovation northwest 2022 conference

Bothell, wash., april 19, 2022 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp) announces that sam lee, phd, president and co-interim chief executive officer, will present a company overview at the hybrid in-person and virtual life science innovation northwest 2022 (lsinw) conference being held april 20-21, 2022 at the washington state convention center in seattle. dr. lee's presentation is scheduled during the neuroscience & pharmaceuticals segment on wednesday, april 20 at 3:25 p.m. pacific time.
COCP Ratings Summary
COCP Quant Ranking